The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pharmacovigilance Outsourcing-Global Market Insights and Sales Trends 2025

Pharmacovigilance Outsourcing-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1867000

No of Pages : 113

Synopsis
Outsourcing pharmacovigilance activities help biopharmaceutical, pharmaceutical, and biotechnology companies to gain accurate and professional insights on ADRs (Adverse Drug Reactions) for a specific drug before it is marketed.
The global Pharmacovigilance Outsourcing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmacovigilance Outsourcing in various end use industries. The expanding demands from the Pre-marketing Services and Post-marketing Services, are propelling Pharmacovigilance Outsourcing market. Contract Research Organizations, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Business Processing Outsourcing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmacovigilance Outsourcing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmacovigilance Outsourcing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmacovigilance Outsourcing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmacovigilance Outsourcing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmacovigilance Outsourcing covered in this report include Accenture, Clinquest Group B.V, Cognizant, LabCorp, IBM, ArisGlobal, ICON, ITClinical and iMEDGlobal, etc.
The global Pharmacovigilance Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Accenture
Clinquest Group B.V
Cognizant
LabCorp
IBM
ArisGlobal
ICON
ITClinical
iMEDGlobal
Foresight Group International AG
TAKE Solutions
PAREXEL
BioClinica
Wipro
United BioSource
Global Pharmacovigilance Outsourcing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacovigilance Outsourcing market, Segment by Type:
Contract Research Organizations
Business Processing Outsourcing
In-House
Contract Outsourcing
Global Pharmacovigilance Outsourcing market, by Application
Pre-marketing Services
Post-marketing Services
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmacovigilance Outsourcing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Pharmacovigilance Outsourcing
1.1 Pharmacovigilance Outsourcing Market Overview
1.1.1 Pharmacovigilance Outsourcing Product Scope
1.1.2 Pharmacovigilance Outsourcing Market Status and Outlook
1.2 Global Pharmacovigilance Outsourcing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmacovigilance Outsourcing Market Size by Region (2018-2029)
1.4 Global Pharmacovigilance Outsourcing Historic Market Size by Region (2018-2023)
1.5 Global Pharmacovigilance Outsourcing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmacovigilance Outsourcing Market Size (2018-2029)
1.6.1 North America Pharmacovigilance Outsourcing Market Size (2018-2029)
1.6.2 Europe Pharmacovigilance Outsourcing Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmacovigilance Outsourcing Market Size (2018-2029)
1.6.4 Latin America Pharmacovigilance Outsourcing Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmacovigilance Outsourcing Market Size (2018-2029)
2 Pharmacovigilance Outsourcing Market by Type
2.1 Introduction
2.1.1 Contract Research Organizations
2.1.2 Business Processing Outsourcing
2.1.3 In-House
2.1.4 Contract Outsourcing
2.2 Global Pharmacovigilance Outsourcing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmacovigilance Outsourcing Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmacovigilance Outsourcing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmacovigilance Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmacovigilance Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmacovigilance Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmacovigilance Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmacovigilance Outsourcing Revenue Breakdown by Type (2018-2029)
3 Pharmacovigilance Outsourcing Market Overview by Application
3.1 Introduction
3.1.1 Pre-marketing Services
3.1.2 Post-marketing Services
3.2 Global Pharmacovigilance Outsourcing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmacovigilance Outsourcing Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmacovigilance Outsourcing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmacovigilance Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmacovigilance Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmacovigilance Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmacovigilance Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmacovigilance Outsourcing Revenue Breakdown by Application (2018-2029)
4 Pharmacovigilance Outsourcing Competition Analysis by Players
4.1 Global Pharmacovigilance Outsourcing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacovigilance Outsourcing as of 2022)
4.3 Date of Key Players Enter into Pharmacovigilance Outsourcing Market
4.4 Global Top Players Pharmacovigilance Outsourcing Headquarters and Area Served
4.5 Key Players Pharmacovigilance Outsourcing Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmacovigilance Outsourcing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Accenture
5.1.1 Accenture Profile
5.1.2 Accenture Main Business
5.1.3 Accenture Pharmacovigilance Outsourcing Products, Services and Solutions
5.1.4 Accenture Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.1.5 Accenture Recent Developments
5.2 Clinquest Group B.V
5.2.1 Clinquest Group B.V Profile
5.2.2 Clinquest Group B.V Main Business
5.2.3 Clinquest Group B.V Pharmacovigilance Outsourcing Products, Services and Solutions
5.2.4 Clinquest Group B.V Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.2.5 Clinquest Group B.V Recent Developments
5.3 Cognizant
5.3.1 Cognizant Profile
5.3.2 Cognizant Main Business
5.3.3 Cognizant Pharmacovigilance Outsourcing Products, Services and Solutions
5.3.4 Cognizant Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.3.5 LabCorp Recent Developments
5.4 LabCorp
5.4.1 LabCorp Profile
5.4.2 LabCorp Main Business
5.4.3 LabCorp Pharmacovigilance Outsourcing Products, Services and Solutions
5.4.4 LabCorp Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.4.5 LabCorp Recent Developments
5.5 IBM
5.5.1 IBM Profile
5.5.2 IBM Main Business
5.5.3 IBM Pharmacovigilance Outsourcing Products, Services and Solutions
5.5.4 IBM Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.5.5 IBM Recent Developments
5.6 ArisGlobal
5.6.1 ArisGlobal Profile
5.6.2 ArisGlobal Main Business
5.6.3 ArisGlobal Pharmacovigilance Outsourcing Products, Services and Solutions
5.6.4 ArisGlobal Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.6.5 ArisGlobal Recent Developments
5.7 ICON
5.7.1 ICON Profile
5.7.2 ICON Main Business
5.7.3 ICON Pharmacovigilance Outsourcing Products, Services and Solutions
5.7.4 ICON Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.7.5 ICON Recent Developments
5.8 ITClinical
5.8.1 ITClinical Profile
5.8.2 ITClinical Main Business
5.8.3 ITClinical Pharmacovigilance Outsourcing Products, Services and Solutions
5.8.4 ITClinical Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.8.5 ITClinical Recent Developments
5.9 iMEDGlobal
5.9.1 iMEDGlobal Profile
5.9.2 iMEDGlobal Main Business
5.9.3 iMEDGlobal Pharmacovigilance Outsourcing Products, Services and Solutions
5.9.4 iMEDGlobal Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.9.5 iMEDGlobal Recent Developments
5.10 Foresight Group International AG
5.10.1 Foresight Group International AG Profile
5.10.2 Foresight Group International AG Main Business
5.10.3 Foresight Group International AG Pharmacovigilance Outsourcing Products, Services and Solutions
5.10.4 Foresight Group International AG Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.10.5 Foresight Group International AG Recent Developments
5.11 TAKE Solutions
5.11.1 TAKE Solutions Profile
5.11.2 TAKE Solutions Main Business
5.11.3 TAKE Solutions Pharmacovigilance Outsourcing Products, Services and Solutions
5.11.4 TAKE Solutions Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.11.5 TAKE Solutions Recent Developments
5.12 PAREXEL
5.12.1 PAREXEL Profile
5.12.2 PAREXEL Main Business
5.12.3 PAREXEL Pharmacovigilance Outsourcing Products, Services and Solutions
5.12.4 PAREXEL Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.12.5 PAREXEL Recent Developments
5.13 BioClinica
5.13.1 BioClinica Profile
5.13.2 BioClinica Main Business
5.13.3 BioClinica Pharmacovigilance Outsourcing Products, Services and Solutions
5.13.4 BioClinica Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.13.5 BioClinica Recent Developments
5.14 Wipro
5.14.1 Wipro Profile
5.14.2 Wipro Main Business
5.14.3 Wipro Pharmacovigilance Outsourcing Products, Services and Solutions
5.14.4 Wipro Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.14.5 Wipro Recent Developments
5.15 United BioSource
5.15.1 United BioSource Profile
5.15.2 United BioSource Main Business
5.15.3 United BioSource Pharmacovigilance Outsourcing Products, Services and Solutions
5.15.4 United BioSource Pharmacovigilance Outsourcing Revenue (US$ Million) & (2018-2023)
5.15.5 United BioSource Recent Developments
6 North America
6.1 North America Pharmacovigilance Outsourcing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmacovigilance Outsourcing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Outsourcing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmacovigilance Outsourcing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Outsourcing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmacovigilance Outsourcing Market Dynamics
11.1 Pharmacovigilance Outsourcing Industry Trends
11.2 Pharmacovigilance Outsourcing Market Drivers
11.3 Pharmacovigilance Outsourcing Market Challenges
11.4 Pharmacovigilance Outsourcing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’